These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14602459)

  • 1. HER2 and proliferation of wound-induced breast carcinoma.
    Tez M; Göçmen E; Ozçelik T
    Lancet; 2003 Nov; 362(9394):1503; author reply 1503. PubMed ID: 14602459
    [No Abstract]   [Full Text] [Related]  

  • 2. HER2 and proliferation of wound-induced breast carcinoma.
    Mannello F; Papa S
    Lancet; 2003 Nov; 362(9394):1503-4. PubMed ID: 14602458
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of HER2 in wound-induced breast carcinoma proliferation.
    Tagliabue E; Agresti R; Carcangiu ML; Ghirelli C; Morelli D; Campiglio M; Martel M; Giovanazzi R; Greco M; Balsari A; Ménard S
    Lancet; 2003 Aug; 362(9383):527-33. PubMed ID: 12932384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
    Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
    Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 and surgery: more questions to answer.
    Spigel DR
    Lancet; 2003 Aug; 362(9383):502-3. PubMed ID: 12932377
    [No Abstract]   [Full Text] [Related]  

  • 7. [ERBB2/HER2: from molecular to clinical oncology].
    Khanson KP; Imianitov EN
    Vopr Onkol; 2002; 48(2):137-45. PubMed ID: 12227060
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative measures of oestrogen receptor and ERBB2 expression.
    Hayes DF
    Lancet Oncol; 2007 Mar; 8(3):184-5. PubMed ID: 17329185
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the ideal HER2 test for Herceptin therapy?
    Jpn J Clin Oncol; 2000 Apr; 30(4):208-9, 211. PubMed ID: 10830993
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.
    Chang CJ; Chiu JH; Tseng LM; Chang CH; Chien TM; Wu CW; Lui WY
    Eur J Clin Invest; 2006 Aug; 36(8):588-96. PubMed ID: 16893382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cloning and expression of the HER2 gene in MCF-7 cells].
    Li R; Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1264-7. PubMed ID: 16234104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-erbB-2 oncoprotein over-expression in breast cancer and its relationship to histology and grade in a Ugandan population.
    Nalwoga H; Odida M; Wabinga H
    East Afr Med J; 2006 Aug; 83(8):411-5. PubMed ID: 17153653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR gene and protein expression in breast cancers.
    Park K; Han S; Shin E; Kim HJ; Kim JY
    Eur J Surg Oncol; 2007 Oct; 33(8):956-60. PubMed ID: 17374474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
    Rivas MA; Tkach M; Beguelin W; Proietti CJ; Rosemblit C; Charreau EH; Elizalde PV; Schillaci R
    Breast Cancer Res Treat; 2010 Jul; 122(1):111-24. PubMed ID: 19760502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
    Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
    Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.
    Pestrin M; Bessi S; Galardi F; Truglia M; Biggeri A; Biagioni C; Cappadona S; Biganzoli L; Giannini A; Di Leo A
    Breast Cancer Res Treat; 2009 Dec; 118(3):523-30. PubMed ID: 19597704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 testing: a review of detection methodologies and their clinical performance.
    Laudadio J; Quigley DI; Tubbs R; Wolff DJ
    Expert Rev Mol Diagn; 2007 Jan; 7(1):53-64. PubMed ID: 17187484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of HER2 gene overexpression in breast carcinoma.
    Ménard S; Tagliabue E; Campiglio M; Pupa SM
    J Cell Physiol; 2000 Feb; 182(2):150-62. PubMed ID: 10623878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.